Skip to content
Stop using now Medical device recall · FDA · Published August 6, 2026

Given Imaging Bravo CF Capsule Device Recall: Risk of Esophageal Injury

Given Imaging recalls Bravo CF capsule delivery devices (5-pack FGS-0635 and 1-pack FGS-0636) due to risk of esophageal injury from capsule detachment. Devices sold before October 20, 2027, with specific lot numbers are affected.

🇺🇸 FDA recall #Z-3090-2026Medical deviceGiven Imaging ›
✎ GovInfoNow plain-language explainer

Given Imaging is recalling Bravo CF capsule delivery devices that may detach from the esophagus, causing risks like aspiration, perforation, or bleeding. This could lead to serious health issues if the device fails to stay in place during pH monitoring. Read more at govinfonow.com/recall/1009701-given-imaging-bravo-cf-capsule-device-recall-risk-of-esophageal.

Source Summary by GovInfoNow · govinfonow.com/recall/1009701-given-imaging-bravo-cf-capsule-device-recall-risk-of-esophageal · Updated September 23, 2026 · FDA enforcement record: FDA #Z-3090-2026

Cite this page

“Given Imaging Bravo CF Capsule Device Recall: Risk of Esophageal Injury.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/1009701-given-imaging-bravo-cf-capsule-device-recall-risk-of-esophageal. Based on FDA recall #Z-3090-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3090-2026%22&limit=1).

The FDA announced on August 6, 2026, that Given Imaging Ltd. is recalling Bravo CF capsule delivery devices due to a hazard where the capsule may fail to attach or detach from the device. Owners should contact the company for a remedy.

How to tell if you have it

  • Given Imaging Bravo CF capsule delivery device, 5-pack, Product Number FGS-0635
  • Given Imaging Bravo CF capsule delivery device, 1-pack, Product Number FGS-0636
  • Product Number FGS-0635 UDI-DI (GTIN) 07290101369707
  • Product Number FGS-0636 UDI-DI (GTIN) 07290101369714
  • Expiration dates prior to and including October 20, 2027 (lot numbers from 64553F up to and including 68912F)

The hazard

The capsule may fail to attach to the esophagus or detach from the delivery device. Risks include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding, laceration of the esophagus, a delay in diagnosis, and foreign bodies remaining in the patient.

Context

GovInfoNow's records show Given Imaging Ltd. has 2 other recalls on record since 2023-02-02. Other recent recalls of similar products include Medline Airway Exam Kit Recall (2026-02-16), Medtronic Bio-Medicus Adult Cannula Kit Recall (2026-05-25), and Medline Recalls Olympus Biopsy Kits (2026-02-16).

How to tell if you have this one

Check for product numbers FGS-0635 (5-pack) or FGS-0636 (1-pack) with expiration dates before October 20, 2027. Lot numbers range from 64553F to 68912F.

  • Brand
    Given Imaging
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Now

    Immediately stop using the device if it has the product numbers FGS-0635 or FGS-0636 with expiration dates before October 20, 2027.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Worldwide distribution. US nationwide including Puerto Rico; Argentina, Australia, Austria, Bahrain, Brazil, Bulgaria, Canada, Cayman Islands, Chile, China, Czech Republic, Dominican Republic, France, Germany, Greece, Hong Kong, India,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 41 days after the firm started it.

1. Firm started the recall: Aug 6, 202612. FDA classified it Class I: Sep 10, 202623. Published in FDA’s Enforcement Report: Sep 16, 202634. Added to GovInfoNow: Sep 23, 202642026
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-3090-2026 (August 6, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-3090-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA